The covalent modification of spectrin in red cell membranes by the lipid peroxidation product 4-hydroxy-2-nonenal

被引:16
作者
Arashiki, Nobuto [1 ]
Otsuka, Yayoi [1 ]
Ito, Daisuke [1 ]
Yang, Mira [1 ]
Komatsu, Tomohiko [1 ]
Sato, Kota [1 ]
Inaba, Mutsumi [1 ]
机构
[1] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Mol Med Lab, Sapporo, Hokkaido 0600818, Japan
关键词
Spectrin; 4-Hydroxy-2-nonenal; Lipid peroxidation; Red cell; Membrane; BLOOD-CELLS; SPHEROCYTOSIS; PROTEINS;
D O I
10.1016/j.bbrc.2009.12.121
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Spectrin strengthens the red cell membrane through its direct association with membrane lipids and through protein-protein interactions. Spectrin loss reduces the membrane stability and results in various types of hereditary spherocytosis. However, less is known about acquired spectrin damage. Here, we showed that alpha- and beta-spectrin in human red cells are the primary targets of the lipid peroxidation product 4-hydroxy-2-nonenal (HNE) by immunoblotting and mass spectrometry analyses. The level of HNE adducts in spectrin (particularly alpha-spectrin) and several other membrane proteins was increased following the HNE treatment of red cell membrane ghosts prepared in the absence of MgATP. In contrast. ghost preparation in the presence of MgATP reduced HNE adduct formation, with preferential beta-spectrin modification and increased cross-linking of the HNE-modified spectrins. Exposure of intact red cells to HNE resulted in selective HNE-spectrin adduct formation with a similar preponderance of HNE-beta-spectrin modifications. These findings indicate that HNE adduction occurs preferentially in spectrin at the interface between the skeletal proteins and lipid bilayer in red cells and suggest that HNE-spectrin adduct aggregation results in the extrusion of damaged spectrin and membrane lipids under physiological and disease conditions. (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1543 / 1547
页数:5
相关论文
共 25 条
[1]
Phosphatidylserine binding sites in erythroid spectrin: Location and implications for membrane stability [J].
An, XL ;
Guo, XH ;
Sum, H ;
Morrow, J ;
Gratzer, W ;
Mohandas, N .
BIOCHEMISTRY, 2004, 43 (02) :310-315
[2]
ANDO K, 1995, BIOL PHARM BULL, V18, P659
[3]
Organizing the diseases fluid membrane bilayer: diseases linked to spectrin and ankyrin [J].
Bennett, Vann ;
Healy, Jane .
TRENDS IN MOLECULAR MEDICINE, 2008, 14 (01) :28-36
[4]
COHEN AM, 1986, BLOOD, V68, P920
[5]
CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES [J].
ESTERBAUER, H ;
SCHAUR, RJ ;
ZOLLNER, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) :81-128
[6]
Study of protein modification by 4-hydroxy-2-nonenal and other short chain aldehydes analyzed by electrospray ionization tandem mass spectrometry [J].
Fenaille, F ;
Guy, PA ;
Tabet, JC .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2003, 14 (03) :215-226
[7]
Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation [J].
Inaba, M ;
Yawata, A ;
Koshino, I ;
Sato, K ;
Takeuchi, M ;
Takakuwa, Y ;
Manno, S ;
Yawata, Y ;
Kanzaki, A ;
Sakai, J ;
Ban, A ;
Ono, K ;
Maede, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (08) :1804-1817
[8]
Ubiquitylation-independent ER-associated degradation of an AE1 mutant associated with dominant hereditary spherocytosis in cattle [J].
Ito, Daisuke ;
Koshino, Ichiro ;
Arashiki, Nobuto ;
Adachi, Hirokazu ;
Tomihari, Mizuki ;
Tamahara, Satoshi ;
Kurogi, Kazuhito ;
Amano, Takashi ;
Ono, Ken-ichiro ;
Inaba, Mutsumi .
JOURNAL OF CELL SCIENCE, 2006, 119 (17) :3602-3612
[9]
Mechanism of Destruction of Microtubule Structures by 4-Hydroxy-2-Nonenal [J].
Kokubo, June ;
Nagatani, Naoki ;
Hiroki, Katsunori ;
Kuroiwa, Kenji ;
Watanabe, Nobuo ;
Arai, Takao .
CELL STRUCTURE AND FUNCTION, 2008, 33 (01) :51-59
[10]
The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain:: the role of Aβ1-42 [J].
Lauderback, CM ;
Hackett, JM ;
Huang, FF ;
Keller, JN ;
Szweda, LI ;
Markesbery, WR ;
Butterfield, DA .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (02) :413-416